ArticleMolecular cancer2023

Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies.

Ismael Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.